Campos-Madueno Edgar I, Aldeia Claudia, Roumet Marie C, Limacher Andreas, Sendi Parham, Endimiani Andrea
Institute for Infectious Diseases (IFIK), University of Bern, Friedbühlstrasse 25, Bern, CH-3001, Switzerland.
Department of Clinical Research, University of Bern, Bern, Switzerland.
Eur J Clin Microbiol Infect Dis. 2025 Apr;44(4):1007-1014. doi: 10.1007/s10096-025-05069-w. Epub 2025 Feb 14.
Living in high-endemic regions increases the risk of intestinal colonization by multidrug-resistant Enterobacterales (MDR-Ent). This study investigated Swiss expatriates residing abroad (≥ 3 months) to assess their colonization status upon returning to Switzerland. Selective culture-based methods were implemented to detect third-generation cephalosporins- (3GC-R), carbapenems- (CR), and colistin-resistant (COL-R) strains. Whole-genome sequencing was used to characterize antimicrobial resistance genes, sequence type (ST), and phylogroup of MDR-Ent. Epidemiological data were analyzed using uni- and multivariable models to identify risk factors, providing crude and adjusted odds ratios (ORs). Among 196 participants living across Africa, Asia, the Americas, and Europe, the overall MDR-Ent colonization prevalence was 42.9%. Continent of residence emerged as a significant risk factor (p = 0.04) for colonization: Africa (adjusted OR = 3.4, 95% CI 1.0-11.0) and Asia (adjusted OR = 4.7, 95% CI 1.5-15.0). Extended-spectrum β-lactamase-producing Escherichia coli (Ec) was the most frequent isolated species (n = 107 out of 119 Ent). Most 3GC-R-Ec possessed bla genes (n = 89; 83.2%) and pandemic lineages were frequent (e.g., ST69 and ST131, n = 18). No CR-Ent were detected, but some COL-R strains (n = 18; of which 15 Ec) harbored the mcr-1.1 gene. Expatriates represent an understudied population at risk of MDR-Ent colonization. This population may contribute to the importation and potential dissemination of dangerous bacteria into low-prevalence countries, as shown in this Swiss study, warranting further investigation and surveillance.
生活在高流行地区会增加多重耐药肠杆菌科细菌(MDR-Ent)肠道定植的风险。本研究调查了旅居国外(≥3个月)的瑞士侨民,以评估他们返回瑞士后的定植状况。采用基于选择性培养的方法检测对第三代头孢菌素耐药(3GC-R)、对碳青霉烯类耐药(CR)和对黏菌素耐药(COL-R)的菌株。使用全基因组测序来鉴定MDR-Ent的抗菌药物耐药基因、序列类型(ST)和系统发育群。采用单变量和多变量模型分析流行病学数据以确定风险因素,给出粗比值比和调整后的比值比(OR)。在居住在非洲、亚洲、美洲和欧洲的196名参与者中,MDR-Ent的总体定植患病率为42.9%。居住的大洲成为定植的一个显著风险因素(p = 0.04):非洲(调整后的OR = 3.4,95%置信区间1.0 - 11.0)和亚洲(调整后的OR = 4.7,95%置信区间1.5 - 15.0)。产超广谱β-内酰胺酶的大肠埃希菌(Ec)是最常分离出的菌种(119株肠杆菌科细菌中有1